This inventor holds 35 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 12 EPO patents, primarily in HIV Inhibition. Top assignees: Janssen Pharmaceutica Nv, Janssen Sciences Ireland Uc, Janssen Pharmaceutica. Active years: 2001-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- B2350 Vosselaar, BE (2005)
- Beerse, BE (2006)
- Vosselaar, BE (2001 - 2014)
- Brasschaat, BE (2012 - 2018)
- (2017 - 2020)
Company Filing History:
26 out of 2,101 
4 out of 111 
2 out of 32 
Years Active: 2001-2020
Areas of Expertise:
Title: **Paul Adriaan Jan Janssen: Innovator in Pharmaceutical Chemistry**
Introduction
Paul Adriaan Jan Janssen, hailing from Vosselaar, Belgium, is a distinguished inventor with a remarkable portfolio of 35 patents. Renowned for his contributions to pharmaceutical chemistry, Janssen's innovative spirit has significantly impacted the field, particularly in the development of HIV replication inhibitors.
Latest Patents
Among his latest inventions is a patent concerning HIV replication inhibiting pyrimidines. This invention outlines a pharmaceutical formulation comprising various N-oxides, quaternary amines, and stereochemically isomeric forms designed to inhibit HIV replication. The detailed formulation includes a range of compounds where the ring structures represent different chemical groups such as phenyl, pyridyl, and pyrimidinyl, along with intricate specifications for varying substituents. This innovation showcases Janssen's dedication to battling viral infections through advanced chemical synthesis.
Career Highlights
Throughout his illustrious career, Paul Janssen has been associated with notable companies, including Janssen Pharmaceutica NV and Janssen Sciences Ireland UC. His work has led to significant advancements in pharmaceutical research and the development of effective medications. His interdisciplinary expertise and innovative approach have established him as a leader in the pharmaceutical sector.
Collaborations
Janssen's journey in innovation has been enriched by collaborations with esteemed individuals such as Jan Heeres and Lucien Maria Henricus Koymans. These partnerships have fostered an environment of creativity and intellectual exchange, further enhancing the development of groundbreaking medicinal compounds.
Conclusion
Paul Adriaan Jan Janssen's contributions to pharmaceutical chemistry continue to leave a lasting legacy in the fight against diseases. His extensive patent portfolio and collaborative spirit illustrate the importance of innovation in advancing healthcare solutions. Through his work, Janssen embodies the essence of a true inventor, committed to making a difference in the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile